Showing results (1-10 of 766) with videos related to
Sort By:
Pageof 77
Current Treatment Options in Oncology|March 5, 2016
Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment SelectionPrashant Kapoor, Jonas Paludo, Stephen M AnsellCancer Treatment and Research|October 4, 2016
Waldenstrom Macroglobulinemia: Genomic Aberrations and TreatmentPrashant Kapoor, Stephen M Ansell, Esteban BraggioBest Practice & Research. Clinical Haematology|November 10, 2016
Prognostic factors and indications for treatment of Waldenström's MacroglobulinemiaRobert A Kyle, Stephen M Ansell, Prashant KapoorExpert Review of Hematology|July 4, 2015
Ibrutinib for the treatment of Waldenström macroglobulinemiaRajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, et al.Expert Review of Anticancer Therapy|July 22, 2015
Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphomaRajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, et al.British Journal of Haematology|November 6, 2024
Checkpoint inhibition in macroglobulinaemiaPrashant KapoorAmerican Journal of Hematology|September 17, 2011
Annual clinical updates in hematological malignancies: a continuing medical education series. Hodgkin lymphoma: 2011 update on diagnosis, risk-stratification, and managementStephen M AnsellClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Nivolumab in the Treatment of Hodgkin LymphomaStephen M AnsellHematology. American Society of Hematology. Education Program|December 4, 2020
Fundamentals of immunology for understanding immunotherapy for lymphomaStephen M AnsellHematology/Oncology Clinics of North America|November 30, 2013
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse)Stephen M AnsellPageof 77